Is there nicotinic modulation of nerve growth factor? Implications for cholinergic therapies in Alzheimer’s disease

作者: Marcus Rattray

DOI: 10.1016/S0006-3223(00)01047-7

关键词: NeuroscienceCentral nervous systemNicotinic agonistTropomyosin receptor kinase ACholinergic neuronAcetylcholineNeurotrophinNerve growth factorCholinergicBiologyBiological psychiatry

摘要: Studies on the neurobiology of nerve growth factor (NGF) reveal a diverse range actions. Through alterations in gene expression, NGF is important maintaining and regulating phenotype neurons that express high-affinity receptor, trkA. Nerve also has rapid action, revealed by its role pain signaling bladder skin. In central nervous system (CNS), an intimate relationship with cholinergic system. It promotes neuron survival after experimental injury but maintains regulates uninjured neurons. addition to these effects mediated neurotransmitter-like action regulate neurotransmission neuronal excitability. Consistent actions system, can enhance function animals lesions been proposed be useful humans Alzheimer's disease (AD); however, problems CNS delivery side (particularly pain) limit clinical efficacy NGF. Drug treatment strategies production may AD. Nicotine one such agent, which, when administered directly hippocampus rats, produces long-lasting elevation production.

参考文章(85)
David L. H. Bennett, Stephen B. McMahon, Marcus Rattray, David L. Shelton, Nerve growth factor and sensory nerve function Birkhäuser Basel. pp. 167- 193 ,(1999) , 10.1007/978-3-0348-8753-3_9
S. Korsching, G. Auburger, R. Heumann, J. Scott, H. Thoenen, Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. The EMBO Journal. ,vol. 4, pp. 1389- 1393 ,(1985) , 10.1002/J.1460-2075.1985.TB03791.X
Matt S. Ramer, John V. Priestley, Stephen B. McMahon, Functional regeneration of sensory axons into the adult spinal cord Nature. ,vol. 403, pp. 312- 316 ,(2000) , 10.1038/35002084
Marzia Malcangio, Neil E. Garrett, Simon Cruwys, David R. Tomlinson, Nerve Growth Factor- and Neurotrophin-3-Induced Changes in Nociceptive Threshold and the Release of Substance P from the Rat Isolated Spinal Cord The Journal of Neuroscience. ,vol. 17, pp. 8459- 8467 ,(1997) , 10.1523/JNEUROSCI.17-21-08459.1997
Karen S. Chen, Merry C. Nishimura, Mark P. Armanini, Craig Crowley, Susan D. Spencer, Heidi S. Phillips, Disruption of a single allele of the nerve growth factor gene results in atrophy of basal forebrain cholinergic neurons and memory deficits. The Journal of Neuroscience. ,vol. 17, pp. 7288- 7296 ,(1997) , 10.1523/JNEUROSCI.17-19-07288.1997
Mark L. Grimes, Jie Zhou, Eric C. Beattie, Eric C. Yuen, Deborah E. Hall, Janice S. Valletta, Kimberly S. Topp, Jennifer H. LaVail, Nigel W. Bunnett, William C. Mobley, Endocytosis of Activated TrkA: Evidence that Nerve Growth Factor Induces Formation of Signaling Endosomes The Journal of Neuroscience. ,vol. 16, pp. 7950- 7964 ,(1996) , 10.1523/JNEUROSCI.16-24-07950.1996
M da Penha Berzaghi, J Cooper, E Castren, F Zafra, M Sofroniew, H Thoenen, D Lindholm, Cholinergic regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) but not neurotrophin-3 (NT-3) mRNA levels in the developing rat hippocampus The Journal of Neuroscience. ,vol. 13, pp. 3818- 3826 ,(1993) , 10.1523/JNEUROSCI.13-09-03818.1993
SA Scott, EJ Mufson, JA Weingartner, KA Skau, KA Crutcher, Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis The Journal of Neuroscience. ,vol. 15, pp. 6213- 6221 ,(1995) , 10.1523/JNEUROSCI.15-09-06213.1995